Dermatomyositis   

If so, what dose-fractionation do you utilize? What other factors do you take into consideration?

Do you taper one DMARD as you uptitrate another versus do you stop the first DMARD and quickly uptitrate another one?

Will you still favor starting with steroids and traditional immunosuppressive agents, move IVIG earlier in your treatment strategy, or start with IVIG...

For example, in the setting of cirrhosis incidentally found on imaging.

Is there a role of immunosuppression or treating underlying malignancy will be enough?

Any indications for triple therapy in the patients with subclinical ILD associated with MDA-5 dermatomyositis?

Muscle disease is quiescent and no other manifestations such as ILD